The panel is a category, not a meeting

Open any 510(k) record FDA Radar has ingested and, most of the time, one of the lines reads Panel: followed by a name like “Cardiovascular Devices Panel of the Medical Devices Advisory Committee.” It reads like provenance — proof that a panel of outside experts looked at this device. For the overwhelming majority of clearances carrying that line, no panel looked at anything. The field means something narrower, and real, and it is not that.

What the field actually is

openFDA’s 510(k) record carries a field, advisory_committee_description (FDA Radar stores it as advisory_committee), that names the medical specialty panel a device type is administratively assigned to for review purposes — derived from the product code, populated on essentially every record, whether or not a human being from that panel was ever in a room with this submission. FDA Radar’s own ingestion renders it as the “Panel:” line, verbatim, in the summary text attached to every 510(k) item — an accurate label for what the field is, and an easy one to misread as a record of what happened.

What an actual meeting requires

A real advisory committee meeting is a different, rarer thing, governed by 21 CFR Part 14. FDA must publish a Federal Register notice at least 15 days before the meeting; background materials are generally posted on FDA’s own site no later than two business days beforehand; the committee hears testimony, asks questions, and in many cases votes — and that vote is a recommendation FDA is not bound to follow. Convening one is reserved for the small number of device submissions each year novel, high-risk, or contested enough to warrant a public hearing. Most 510(k)s, and most PMAs, are decided without one ever being scheduled — the panel field on the record is populated regardless.

The field names who would review a device like this, not who did. Reading it as the second thing costs nothing on ninety-nine records and misleads on the hundredth, with no marker on the record itself telling you which one you’re looking at.

When a meeting notice does show up

When FDA does convene one, the notice reaches the Federal Register feed FDA Radar ingests directly — and lands in the same bucket as any other miscellaneous filing. FDA Radar’s categorizer sorts a Federal Register document into FDA Guidance or Classification Change only on specific title conventions; a meeting announcement matches neither, so it falls to the general Federal Register Noticebucket, with no field marking it a meeting and nothing connecting it forward to whatever FDA eventually decides. The notice is an invitation to a hearing, not its outcome; the vote, when the meeting happens, posts afterward to FDA’s own advisory committee calendar, not as a new Federal Register document, and the decision it was about can land weeks or months later still, in a submission record with no field pointing back to the meeting that preceded it.

The practice

Read the Panel line on a clearance for what it names — a specialty category, not an event — and if the question is genuinely whether an advisory committee met on a device or a device type, check FDA’s own advisory committee calendar rather than infer it from a field that is populated whether or not one did. When a meeting notice does appear in the feed, read it as the opening of a public process with an outcome that will post elsewhere, later, unlinked. What a specific panel assignment or a specific meeting implies about a specific device is a judgment for a regulatory professional reading the record itself — this is regulatory intelligence and method, never regulatory advice about a specific filing.

FDA Radar ingests the Federal Register directly, every business day; see what we monitor and how often for the rest of the pipeline. The Panel field on a 510(k) is real, ingested, and exactly as narrow as FDA defines it.